Bioorganic and Medicinal Chemistry Letters p. 1547 - 1552 (1996)
Update date:2022-08-02
Topics:
Woods, Keith W.
Brooks, Clint D. W.
Maki, Robert G.
Rodriques, Karen E.
Bouska, Jennifer B.
Young, Patrick
Bell, Randy L.
Carter, George W.
Reference FLAP inhibitors 1 and 2 were converted into the corresponding O-acetic acid oxime congeners 8 and 11a, respectively, resulting in potent, orally active, leukotriene biosynthesis inhibitors. An attempt to create a dual FLAP and direct 5-LO inhibitor by replacing the carboxylate group in 1 with the N-hydroxyurea pharmacophore did not provide superior inhibitors.
View Morejiangsu haian chemical co.,ltd.
Contact:86-513-15851283853
Address:No.99,Changjiang West Road,Haian County,Jiangsu Province,China
shanghai Tauto Biotech Co., Ltd
website:http://www.tautobiotech.com/en/index.htm
Contact:+86-21-51320588 ext. 8025
Address:No. 326, Aidisheng Rd , Zhangjiang Hi-tech Park, Shanghai , P.R.CHINA
SHENYANG COMEBOARD TECHNOLOGY CO., LTD
Contact:+86-24-25724626
Address:Room2210,Tianbao International Building,No.8-1 Weigong South Street,Tiexi District,Shenyang,China
Beijing Cooperate Pharmaceutical Co.,Ltd
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
ShanDong XinDa Chemical CO.,LTD(expird)
Contact:086-0311-87580543
Address:No.168, High Technology Development Zone Jinan Shandong China
Doi:10.1248/cpb.33.4275
(1985)Doi:10.1080/00397919908086040
(1999)Doi:10.1016/j.tet.2006.07.007
(2006)Doi:10.1021/acs.joc.6b02102
(2016)Doi:10.1007/s12272-013-0006-9
(2013)Doi:10.1002/hlca.201200490
(2012)